Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance

by Xuezhi Cao, Yong Liang, Zhenxiang Hu, Huiyu Li, Jiaming Yang, Eric J. Hsu, Jiankun Zhu, Jin Zhou, Yang-Xin Fu
Published 2021-10-01